Replies to post #659766 on NorthWest Biotherapeutics Inc (NWBO)

[CrashOverride]

If no RFI letter is issued by MHRA there is no Phase 2 assessment hence why majority of decisions are made in Phase 1. Read more below:

https://uk.practicallaw.thomsonreuters.com/w-029-1301?transitionType=Default&contextData=(sc.Default)&firstPage=true#kh_relatedContentOffset

I do not expect MHRA will need Phase 2 assessment for DCVax which they already know works given Specials, JAMA, PIM designation, orphan designation, and patient advocacy.

I could be wrong but I do not really care as it will be approved in 2024. I stand by my timetable of March 2024 as it has a high probability of being reached.